Know Cancer

or
forgot password

Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients: A Prospective Observational Study ("EXO-PPP Study")


N/A
18 Years
N/A
Open (Enrolling)
Both
Gastric Cancer

Thank you

Trial Information

Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients: A Prospective Observational Study ("EXO-PPP Study")


Inclusion Criteria:



Subjects eligible for enrollment must meet all of the following criteria:

1. Provide signed informed consent. The subject is capable of understanding and
complying with parameters as outlined in the protocol and able to sign informed
consent, approved by the Independent Ethic Committee (IEC)/Institutional Review Board
(IRB) prior to the initiation of any study-specific procedures

2. Men or women aged >= 18 years.

3. Eastern Cooperative Oncology Group Performance Status (ECOG) <= 2.

4. Histologically confirmed adenocarcinoma of the stomach, gastroesophageal junction or
esophagus.

5. Metastatic disease or locally advanced disease not amenable to curative surgery.

6. Radiographically assessable, non-measurable disease or measurable disease as per
RECIST criteria.

7. Life expectancy of at least 12 weeks from the time of enrollment.

8. No other malignancy within the past 5 years except adequately treated basal cell or
squamous cell skin cancer or carcinoma in situ of the cervix.

9. No prior chemotherapy for advanced disease.

Exclusion Criteria:

Subjects meeting any of the following criteria must not be enrolled in the study:

1. Gastric carcinoid, sarcomas, or squamous cell cancer.

2. Pregnant or lactating females.

3. Significant neurological or psychiatric disorders (psychotic disorders, dementia or
seizures) that would prohibit the understanding and giving of informed consent.

4. Active Hepatitis B or C or history of an HIV infection.

5. Active uncontrolled infection.

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

• Characterization of the molecular profile in tumor derived exosomes from advanced gastric cancer patients undergoing first-line chemotherapy

Outcome Time Frame:

Up to 2 years from start of study

Safety Issue:

No

Principal Investigator

HECTOR PEINADO, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Spanish National Cancer Research Centre (CNIO)

Authority:

Spain: Spanish National Health Institute - Spanish Ministry of Health, Social Services and Equality

Study ID:

EXO-PPP study

NCT ID:

NCT01779583

Start Date:

January 2013

Completion Date:

Related Keywords:

  • Gastric Cancer
  • Advanced gastric cancer
  • Stomach Neoplasms

Name

Location